{
    "clinical_study": {
        "@rank": "75678", 
        "arm_group": {
            "arm_group_label": "Anlotinib hydrochloric capsule", 
            "arm_group_type": "Experimental", 
            "description": "Anlotinib hydrochloric capsule 12mg QD po and it should be continued until disease progression or intolerable toxicity or patients withdrawal of consent"
        }, 
        "brief_summary": {
            "textblock": "Anlotibib (AL3818) is a kind of innovative medicines approved by State Food and Drug\n      Administration\uff08SFDA:2011L00661\uff09 which was researched by Jiangsu Chia-tai Tianqing\n      Pharmaceutical Co., Ltd. Anlotinib is a kinase inhibitor of receptor tyrosine with\n      multi-targets, especially for VEGFR2\u3001VEGFR3\u3001PDGFR\u03b2 and c-Kit. It has the obvious resistance\n      to new angiogenesis. The trial is to explore the efficacy and safety profile of Anlotinib in\n      patients with advanced Renal Cell Carcinoma(RCC) that have failed to TKIs therapy."
        }, 
        "brief_title": "Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma\uff08RCC\uff09That Have Failed Or Are Intolerant To TKIs Therapy", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Renal Cell Carcinoma\uff08RCC\uff09", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Renal Cell"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1.Patients with histologically confirmed advanced renal cell carcinoma including\n             clear cell component and not available for surgery\n\n          -  2.Previously Failed Or Are Intolerant To TKIs Therapy(such as sunitinib, Sorafenib)\n\n          -  3.With measurable disease (using RECIST1.1)\n\n          -  4.18-75years,ECOG PS:0-1,Life expectancy of more than 3 months\n\n          -  5.Last TKIs Therapy\u22654 weeks\n\n          -  6.Main organs function is normal\n\n          -  7.Signed and dated informed consent\n\n        Exclusion Criteria:\n\n          -  1.patients has many influence factors toward oral medications\n\n          -  2.Known brain metastases\n\n          -  3.patients with severe and failed to controlled diseases,including: suboptimal blood\n             pressure control;suffering from myocardial ischemia or above grade I myocardial\n             infarction, arrhythmias and Class I heart failure;activity or failure to control\n             severe infections;liver disease such as cirrhosis, decompensated liver disease,\n             chronic active hepatitis;poorly controlled diabetes (FBG)>10mmol/L);urine\n             protein\u2265++,etc.\n\n          -  4.patients failed to heal wounds or fractures for Long-term\n\n          -  5.patients occurred venous thromboembolic events within 6 months\n\n          -  6.patients has HIV-positive or organ transplantation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02072044", 
            "org_study_id": "ALTN-06-IIB"
        }, 
        "intervention": {
            "arm_group_label": "Anlotinib hydrochloric capsule", 
            "description": "Anlotinib 12 mg p.o. qd", 
            "intervention_name": "Anlotinib hydrochloric capsule", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Renal Cell Carcinoma\uff08RCC\uff09", 
            "Anlotinib"
        ], 
        "lastchanged_date": "February 24, 2014", 
        "link": [
            {
                "description": "Renal Cancer", 
                "url": "http://rarediseases.info.nih.gov/gard/7545/renal-cancer/resources/1"
            }, 
            {
                "description": "Kidney Cancer", 
                "url": "http://rarediseases.info.nih.gov/gard/9339/kidney-cancer/resources/1"
            }, 
            {
                "description": "Cancer", 
                "url": "http://clinicaltrials.gov/ct2/bye/uQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS90B7x061nuQoPmdt."
            }, 
            {
                "description": "Drug Information", 
                "url": "http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp"
            }
        ], 
        "location": [
            {
                "contact": {
                    "last_name": "Xu Zhang, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100039"
                    }, 
                    "name": "Chinese PLA General Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hanzhong Li, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100005"
                    }, 
                    "name": "Peking Union Medical College Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jianhui Ma, Doctor"
                }, 
                "contact_backup": {
                    "last_name": "Aiping Zhou, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100021"
                    }, 
                    "name": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences"
                }, 
                "investigator": [
                    {
                        "last_name": "Jianhui Ma, Doctor", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Aiping Zhou, Doctor", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hong Luo, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Chongqing", 
                        "zip": "404100"
                    }, 
                    "name": "Chongqing Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jun Li, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Lanzhou", 
                        "country": "China", 
                        "state": "Gansu", 
                        "zip": "730050"
                    }, 
                    "name": "Gansu Province Tumor Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fangjian Zhou, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510000"
                    }, 
                    "name": "Sun Yat-Sen University Cancer Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Xianzhong Bai, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanning", 
                        "country": "China", 
                        "state": "Guangxi", 
                        "zip": "530021"
                    }, 
                    "name": "Guangxi medical university affiliated tumor hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Yuxian Bai, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Haerbin", 
                        "country": "China", 
                        "state": "Heilongjiang", 
                        "zip": "150000"
                    }, 
                    "name": "Harbin medical university affiliated tumor hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Yingxia Chen Chen, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "210000"
                    }, 
                    "name": "The 81st Hospital of Chinese PLA"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ying Chen, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Changchun", 
                        "country": "China", 
                        "state": "Jilin", 
                        "zip": "132000"
                    }, 
                    "name": "Jilin Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Xiaodong Xie, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110000"
                    }, 
                    "name": "China General Hospital of Shenyang Military Region"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cheng Fu, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110042"
                    }, 
                    "name": "Liaoning Province Tumor Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Xiuwen Wang Wang, Doctor"
                }, 
                "contact_backup": {
                    "last_name": "Benkang Shi Shi, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250012"
                    }, 
                    "name": "Qilu Hospital\uff0cShandong University"
                }, 
                "investigator": [
                    {
                        "last_name": "Xiuwen Wang, Doctor", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Benkang Shi, Doctor", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sichuan Hou, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Qingdao", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "266000"
                    }, 
                    "name": "Qingdao Municial Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dingwei Ye, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200000"
                    }, 
                    "name": "Cancer Hospital of Fudan University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jiyan Liu Liu, Dontor"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610041"
                    }, 
                    "name": "West China Hospital\uff0cSichuan University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Xiubao Ren, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China", 
                        "state": "Tianjin", 
                        "zip": "300000"
                    }, 
                    "name": "Tianjin Medical University Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Study of Anlotinib(AL3818) Hydrochloric Capsule in Patients With Advanced Renal Cell Carcinoma(RCC) That Have Failed Or Are Intolerant To TKIs Therapy", 
        "overall_contact": {
            "email": "zhouap1825@126.com", 
            "last_name": "Aiping Zhou, Doctor"
        }, 
        "overall_contact_backup": {
            "last_name": "Jianhui Ma, Doctor"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "China: Food and Drug Administration"
            ]
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The PFS time is defined as time from randomization to locoregional or systemic recurrence, second malignancy or death due to any cause; censored observations will be the last date of: \"death\", \"last tumor assessment\", \"last follow up date\" or \"last date in drug log\"", 
            "measure": "Progress Free Survival (PFS)", 
            "safety_issue": "No", 
            "time_frame": "each 42 days up to PD or death (up to 36 months)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02072044"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate the effectiveness of Anlotinib Hydrochloric Capsule by enhanced CT/MRI scan every two cycles. Objective Response Rate (ORR) is defined as participants who had complete response (CR) or partial response(PR) divided by the total number of patients.", 
                "measure": "Objective Response Rate", 
                "safety_issue": "No", 
                "time_frame": "each 42 days up to intolerance the toxicity or PD (up to 36 months)"
            }, 
            {
                "description": "To evaluate the effectiveness of Anlotinib Hydrochloric Capsule by enhanced CT/MRI scan every two cycles. Disease Control Rate (DCR) defined as the percentage of participants with Disease Control best overall response (complete response, partial response or stable disease).", 
                "measure": "Disease Control Rate (DCR)", 
                "safety_issue": "No", 
                "time_frame": "each 42 days up to intolerance the toxicity or PD (up to 36 months)"
            }, 
            {
                "description": "OS was defined as time from date of randomization to date of death due to any cause.  For participants still alive at the time of analysis, OS time was censored on last date that participants were known to be alive.", 
                "measure": "Overall Survival (OS)", 
                "safety_issue": "No", 
                "time_frame": "From randomization until death (up to 36 months)"
            }
        ], 
        "source": "Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}